Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Adaptimmune Therapeutics PLC Transaction History

Commonwealth Of Pennsylvania Public School Empls Retrmt Sys

$15.5 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 09, 2023	BUY	$1.06 - $2.16 $15,144 - $30,859	14,287 New	14,287 $15,000

Others Institutions Holding ADAP

# of Institutions

Shares Held

145M

Call Options Held

60.8K

Put Options Held

5.8K

Matrix Capital Management Company, LP Waltham, MA

37.7M
Shares

$23 Million
1.71% of portfolio
Eco R1 Capital, LLC San Francisco, CA

27.4M
Shares

$16.7 Million
1.13% of portfolio
Nea Management Company, LLC Timonium, MD

17.1M
Shares

$10.4 Million
1.24% of portfolio
Long Focus Capital Management, LLC San Juan, PR

13.3M
Shares

$8.11 Million
0.46% of portfolio
Baillie Gifford & CO

11.8M
Shares

$7.21 Million
0.01% of portfolio

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $99.7M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.

Account